A major US pharmaceutical company will settle over seven billion dollars in lawsuits alleging a link between its baby powder and ovarian cancer. The $7.9 billion payout resolves claims from thousands of individuals who argue the talc-based powder caused them to develop the disease. These cases have spanned years, with plaintiffs asserting the company knew of potential contamination with asbestos and failed to warn consumers. The settlement aims to provide compensation to those affected and avoid further lengthy court battles. While the company maintains its product is safe, the significant financial agreement signals a major outcome in the ongoing litigation. This resolution doesn't necessarily end all legal challenges, as future claims may still arise.